The new artificial intelligence model can help in the diagnosis of tuberculosis in remote areas.
British scientists find a new way that could diagnose TB in just a few days instead of months.
Tuberculosis may seem like a deadly disease in the past, but that is far from the real scenario.
New findings published in Antimicrobial Agents and Chemotherapy reveal that a compound found in drugs used to treat glaucoma--known as ethoxzolamide--may also be helpful in turning off tuberculosis bacteria's ability to sense immune system attacks, making them shorter and more effective.
Tuberculosis can be deadly. In fact, it kills about one to two million people each year. Now, scientists have found the origins of this infection.
Half a million people fell sick with dangerous superbug strains of tuberculosis (TB) in 2012, but fewer than one in four were diagnosed, putting the rest at risk of dying due to the wrong medicines or no treatment at all.
Researchers are ready to start human tests of new experimental vaccines for tuberculosis (TB), one of humanity’s oldest diseases, thanks to the combined effort of scientists from over 35 research organisations.
Scientists have discovered a natural antibiotic turns out to be a lethal weapon in the fight against tuberculosis, since it has an unexpected dual action that dramatically reduces the probability that TB bacteria will become resistant.